DAXX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.879200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.928610E-01
Normal-vs-Stage2
7.343800E-03
Normal-vs-Stage3
1.253170E-01
Normal-vs-Stage4
3.106600E-01
Stage1-vs-Stage2
2.235400E-01
Stage1-vs-Stage3
9.698000E-01
Stage1-vs-Stage4
3.828000E-02
Stage2-vs-Stage3
3.043800E-01
Stage2-vs-Stage4
3.322200E-01
Stage3-vs-Stage4
2.100400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.684400E-03
Normal-vs-AfricanAmerican
2.706400E-01
Normal-vs-Asian
3.039600E-01
Caucasian-vs-AfricanAmerican
9.048800E-01
Caucasian-vs-Asian
6.102200E-01
AfricanAmerican-vs-Asian
6.585000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.837300E-03
Normal-vs-Female
1.339920E-02
Male-vs-Female
2.931600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.667220E-01
Normal-vs-Age(41-60Yrs)
2.880800E-01
Normal-vs-Age(61-80Yrs)
1.157570E-02
Normal-vs-Age(81-100Yrs)
1.178380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.827600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.704000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.390800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.298400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.019600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.032600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.751600E-02
Normal-vs-Daily Drinker
4.101300E-03
Normal-vs-Weekly Drinker
3.066200E-01
Normal-vs-Occasional Drinker
4.605700E-02
Normal-vs-Social Drinker
2.287200E-01
Non Drinker-vs-Daily Drinker
1.055440E-01
Non Drinker-vs-Weekly Drinker
6.999000E-01
Non Drinker-vs-Occasional Drinker
6.237000E-01
Non Drinker-vs-Social Drinker
3.463600E-01
Daily Drinker-vs-Weekly Drinker
3.297700E-02
Daily Drinker-vs-Occasional Drinker
2.443500E-02
Daily Drinker-vs-Social Drinker
2.893600E-01
Weekly Drinker-vs-Occasional Drinker
8.372400E-01
Weekly Drinker-vs-Social Drinker
9.694100E-02
Occasional Drinker-vs-Social Drinker
1.211560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.121800E-01
Normal-vs-Grade 2
6.023400E-01
Normal-vs-Grade 3
6.370000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.361370E-01
Grade 1-vs-Grade 3
3.303600E-01
Grade 1-vs-Grade 4
4.121800E-01
Grade 2-vs-Grade 3
4.186200E-01
Grade 2-vs-Grade 4
6.023400E-01
Grade 3-vs-Grade 4
6.370000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.213900E-02
Normal-vs-NonDiabetic
2.619800E-01
Diabetic-vs-NonDiabetic
9.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.535000E-01
Normal-vs-NoPancreatitis
4.977400E-03
Pancreatitis-vs-NoPancreatitis
8.121200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.074500E-02
Normal-vs-N1
6.982900E-03
N0-vs-N1
7.220800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.863000E-01
Normal-vs-TP53-NonMutant
2.869600E-02
TP53-Mutant-vs-TP53-NonMutant
3.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
